French authorities (AFSSAPS) have evaluated favourably our dossier of Fluoxetine 20 mg, dispersible scored tablets. Marketing authorization is expected in October 2007 and product launch in France, in January 2008.

The dossier is available for out-licence in Europe. Please contact our business development department for further information (business@substipharm.com).

French authorities (AFSSAPS) have evaluated favourably our dossier of Domperidone 10 mg, ordispersible tablets. Marketing authorization is expected in October 2007 and product launch in France, in January 2008.

The dossier is available for out-licence in Europe. Please contact our Business Development Department for further information (business@substipharm.com).